Casimersen - Sarepta Therapeutics
At a glance
- Drug Originator University of Western Australia
- Drug Licenced by Sarepta Therapeutics
- Drug Class Antisense oligonucleotides; Morpholines
- Mechanism of Action Dystrophin expression stimulants; RNA interference
- USA Patent Applicants SAREPTA THERAPS INC
- USA Patents 28
- NDAs 1
- International Patents 85

Disclaimer